GlassScriptPhysician profile
Mary Weber
NPI 1669802187
$3,430.85
in general payments reported to CMS, 2019-2025
26 companies · $823 in 2025
The $823 reported for 2025 was more than what 84% of Primary Care providers received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $136 · 2022: $304 · 2023: $830 · 2024: $1,339 · 2025: $823.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,703 · Travel and Lodging: $289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,703.05 |
| Travel and Lodging | $288.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $529.14 | 2023-2025 | Watchman Flx, Watchman |
| E.R. Squibb & Sons, L.L.C. | $451.66 | 2022-2025 | Eliquis, Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $409.57 | 2021-2025 | Lifevest |
| Scpharmaceuticals INC. | $232.05 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $231.58 | 2021-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $224.91 | 2021-2025 | Farxiga |
| Pfizer INC. | $193.13 | 2023-2025 | |
| Edwards Lifesciences Corporation | $188.74 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Novartis Pharmaceuticals Corporation | $158.90 | 2023-2025 | |
| Amgen INC. | $153.91 | 2023-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $99.03 | 2022-2025 | Verquvo |
| Esperion Therapeutics, INC. | $75.01 | 2023-2025 | Nexletol |
| Medtronic, INC. | $73.64 | 2023-2024 | Linq II, Aurora Ev-Icd Mri Surescan |
| Lexicon Pharmaceuticals, INC. | $64.31 | 2023-2024 | Inpefa |
| Alnylam Pharmaceuticals INC. | $48.23 | 2025 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lantheus Medical Imaging, INC. | $46.60 | 2022-2023 | Definity |
| Chiesi USA, INC. | $42.69 | 2022 | |
| Janssen Pharmaceuticals, INC | $36.58 | 2023 | Xarelto |
| Regeneron Healthcare Solutions, INC. | $33.29 | 2023-2025 | Evkeeza |
| Abbott Laboratories | $31.96 | 2023 | Amplatzer Amulet |
| Kiniksa Pharmaceuticals, LTD. | $23.24 | 2023 | Arcalyst |
| Irhythm Technologies, INC. | $22.30 | 2024 | Zio Xt Patch, Zio Monitor |
| Novo Nordisk INC | $19.20 | 2024 | Wegovy |
| Lilly USA, LLC | $14.28 | 2025 | Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $13.86 | 2025 | |
| Atricure, INC. | $13.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Weber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.